Bridgebio PharmaBBIO 
$28.532.74%24h
2.74%24h
Global rank2666
Market cap$4.96B
Change 7d3.03%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Bridgebio Pharma (BBIO)
As of January 2025, Bridgebio Pharma has a market cap of $4.96B. This makes Bridgebio Pharma the world's 2666th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Bridgebio Pharma from 2019 to 2024
-
Value:-
Market cap history of Bridgebio Pharma from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $6.75B | -3.89% |
| 2023 | $7.02B | 429.79% |
| 2022 | $1.33B | -54.32% |
| 2021 | $2.90B | -76.54% |
| 2020 | $12.37B | 102.88% |
| 2019 | $6.10B | - |
BBIO Market Cap Today is $4.96B 2.74% - 21 Jan 2025
View largest stocks by market cap 
